Arctoris is featured in a video from the Royal Society of Biology’s Biology for a Better Tomorrow series exploring how technological innovation is transforming the drug discovery process.
The video highlights the longstanding challenges in pharmaceutical R&D, where traditional approaches to drug discovery are often slow, manual, and resource-intensive. Emerging technologies such as laboratory automation, robotics, and advanced data analytics are helping to modernize how experiments are conducted and how biological data is generated.
Arctoris is presented as an example of a company advancing this transformation by combining automated laboratory infrastructure with expertise in structural biology, protein sciences, and computational analysis. The company’s Ulysses® automated platform enables rapid testing of large numbers of compounds, supporting researchers in identifying promising drug candidates more efficiently.
By integrating robotics with advanced data processing capabilities, automated platforms can generate highly reproducible datasets and allow scientists to analyze large volumes of experimental data more effectively. These capabilities are increasingly important as modern drug discovery relies on rapid iteration between computational hypothesis generation and experimental validation.
